NURS 660 Final Review Study Guide | Advanced Nursing Practice Exam Prep

NURS 660 Final Review | COMPLETE
QUESTIONS WITH 100% RATED
CORRECT ANSWERS | GRADED A+ |
2026-2027




The effects of GLP-1 Agonist medications include all
of the following EXCEPT:
Select one:
a. glucagon induced gluconeogenesis
b. increased satiety
c. improved glycemic control
d. glucose dependent insulin secretion -CORRECT
ANSWER>> glucagon induced gluconeogenesis

,A common adverse effect with SGLT-2 Inhibitors is:
Select one:
a. edema
b. mycotic infection
c. hypertension
d. weight gain -CORRECT ANSWER>> Mycotic Infection


Due to the increased risk for hypoglycemia, the
following two medication classes should not be
used in combination:
Select one:
a. insulin and metformin
b. insulin and sulfonylurea
c. insulin and thiazolidinedione
d. insulin and acarbose -CORRECT ANSWER>> Insulin
and Sulfonylurea

,A patient is 66 inches in height, weighing 200 lbs,
and newly diagnosed with type 2 diabetes mellitus
(DM). The A1c is 7.1%. What is the best initial
treatment?
Select one:
a. Diet, exercise, and metformin
b. No treatment at this time
c. Diet and exercise
d. Diet, exercise, and exogenous insulin -CORRECT
ANSWER>> Diet and exercise, Diet, exercise, and

metformin


Which medication is an insulin secretagogue
(mechanism of action is to secrete insulin)?
Select one:
a. acarbose (alpha-glucosidase inhibitor)

, b. empagliflozin (SGLT2 Inhibitor)
c. rosiglitazone (thiazolidinedione)
d. glipizide (sulfonylurea) -CORRECT ANSWER>>
glipizide (sulfonylurea)


The "ominous octet" includes all of the following
EXCEPT:
Select one:
a. insulin resistance
b. decreased insulin production
c. decreased incretin hormones
d. increased incretin hormones -CORRECT ANSWER>>
increased incretin hormones


In which patient would the clinician NOT initiate
metformin?
Select one: